Nasdaq GlobeNewswire

SpeeDx receives FDA clearance for Mycoplasma genitalium product

Del

SYDNEY, Australia, April 19, 2018 (GLOBE NEWSWIRE) -- SpeeDx's  Resistance Plus ® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale in the United States through the company's recently incorporated US entity, SpeeDx Inc. The announcement coincides with the FDA registration of the Australian parent company - SpeeDx Pty Ltd - as a Medical Device Manufacturing Establishment, and clinical trials remain on-track for the  Resistance Plus MG assay.*

The  Resistance Plus MG Positive Control kit contains synthetic DNA to simulate Mycoplasma genitalium, as well as five mutations known to confer resistance to macrolide antibiotics. Macrolide-resistant M. genitalium is a challenging sexually transmitted infection (STI), and global management guidelines are currently being adapted to deal with the rise in resistance. "This is an important product in our portfolio," said Elisa Mokany, Chief Technology Officer for SpeeDx. "M. genitalium is very difficult to culture, and positive material for quality control can be hard to come by."  

SpeeDx's  Resistance Plus MG assay is the first commercially available diagnostic test that simultaneously detects M. genitalium and genetic markers for antimicrobial resistance, and has been widely adopted across Europe, Australia and New Zealand since gaining CE marking in 2016. "We have a strong focus on tackling the global antimicrobial resistance problem," said Colin Denver, CEO of SpeeDx. "STIs are set to become the first incurable bacterial infections, and our  Resistance Plus line of diagnostic tests empowers clinicians to make informed treatment decisions."

About Mycoplasma genitalium

M. genitalium can cause symptoms such as urethritis, cervicitis, endometritis and pelvic inflammatory disease. In recent studies, it has been found to have a higher prevalence than gonorrhoea. Like gonorrhoea, M. genitalium is evolving into a so-called STI superbug that is becoming resistant to many antibiotic treatments, leading to exceedingly difficult-to-treat infections and threatening global public health.

Macrolide antibiotics, specifically azithromycin, are the first-line treatments for the rapidly growing problem of M. genitalium STIs, but resistance to these antibiotics has increased by up to 60 percent in several countries. This development led guidelines on M. genitalium infections in Europe and Australia recommending the molecular detection of M. genitalium be complemented with an assay capable of detecting macrolide resistance-associated mutations.

About SpeeDx

Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease. Currently, SpeeDx markets the only CE-marked and TGA approved commercial molecular test for the STI M. genitalium(ResistancePlus® MG*) that combines detection of the disease with detection of markers for antibiotic resistance. 
For more information about SpeeDx please see: http://plexpcr.com

*  Not available in the US

Contacts for SpeeDx:
Madeline O'Donoghue
madelineo@speedx.com.au
+61 2 8212 8512 (ext 008)




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SpeeDx Pty Ltd via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

UPDATE - Euro Manganese Inc. Closes Plant Site Option Agreement and Provides Operational Update18.10.2018 04:01Pressemelding

VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V/ASX: EMN) (“EMN” or the "Company") announced today that it has waived the conditions precedent to the closing of an Option Agreement to acquire EP Chvaletice s.r.o. (“EPCS”), a Czech operating company whose principal asset is a large parcel of industrial zoned land adjacent to the Chvaletice Manganese Project, where EMN proposes to develop its high-purity manganese processing facility. In addition, EMN is pleased to provide an operational update for its Chvaletice Manganese Project. Due Diligence Completed and First Payment made on EPCS Option Agreement Following the satisfactory completion of an environmental, financial and legal due diligence review, the Company reports that it has made the first instalment of 14 million Czech Korunas (approx. CAD$815,000) related to an option agreement dated August 13, 2018 giving it the right to acquire a 100% interest in EPCS (the “Option Agreement”). EPCS is

Euro Manganese Inc. Closes Plant Site Option Agreement and Provides Operational Update17.10.2018 22:58Pressemelding

VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V/ASX: EMN) (“EMN” or the "Company") announced today that it has waived the conditions precedent to the closing of an Option Agreement to acquire EP Chvaletice s.r.o. (“EPCS”), a Czech operating company whose principal asset is a large parcel of industrial zoned land adjacent to the Chvaletice Manganese Project, where EMN proposes to develop its high-purity manganese processing facility. In addition, EMN is pleased to provide an operational update for its Chvaletice Manganese Project. Due Diligence Completed and First Payment made on EPCS Option Agreement Following the satisfactory completion of an environmental, financial and legal due diligence review, the Company reports that it has made the first instalment of 14 million Czech Korunas (approx. CAD$815,000) related to an option agreement dated August 13, 2018 giving it the right to acquire a 100% interest in EPCS (the “Option Agreement”). EPCS is

Constellation Brands Names Bill Newlands Next CEO17.10.2018 22:55Pressemelding

Newlands to Succeed Rob Sands Effective March 1, 2019; Sands to Become Executive Chair VICTOR, N.Y., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, today announced Bill Newlands will assume the role of president and chief executive officer (CEO), succeeding current CEO Rob Sands, on March 1, 2019. Also effective March 1, 2019, Rob Sands will assume the role of executive chair. Richard Sands, who is currently serving in the role of executive chair, will assume the role of executive vice chair on March 1, 2019. “Since joining Constellation Brands in 2015, Bill has made a significant impact on our company, finding ways to leverage our unique capabilities as a leading total beverage alcohol provider to meet consumers’ evolving needs and accelerate growth,” said Constellation Brands’ CEO Rob Sands. “Bill understands what it takes to succeed in this rapidly evolving market and he’s the right person to lead our company g

Elite Capital & Gas broadens financial services and signs a deal with Tabarak Investment Capital Limited17.10.2018 16:30Pressemelding

DUBAI, United Arab Emirates, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Today the President of Elite Petro & Gas, Mr. George Matharu and the President of Tabarak Investment Capital Limited (Investment Bank), Dr. Mohamed Ahmadi announced a deal in which the two companies will use their combined resources to execute physical commodity trades, and provide banking and finance facilities for oil and gas transactions. The alliance between the two entities will also allow compliance related activities to be carried out from two major international hubs of London and Dubai. This increases the international presence of both companies. Additionally, Elite Petro & Gas (“EPG”) has recently formed relationships with the owners of a number of high profile European, South American and Chinese projects, which EPG and Tabarak can work on together. Tabarak Investment Capital Limited is a regulated investment bank by Dubai Financial Services Authority and incorporated in the Dubai International Financial Centre.

MASH ANNOUNCES EUR 50M EQUITY ROUND AND LAUNCH OF EUROPE'S FIRST STO17.10.2018 15:14Pressemelding

Mash Group, a ten year old digital lender and pay later solution provider, announced a EUR 50M equity round and the launch of a Security Token Offering (STO) Helsinki, 17th October: Mash Group Plc, a Finnish FinTech company specializing in consumer lending and pay later solutions, today announced that pre-registration has begun for a Securitized Token Offering (STO). Mash is partnering with DLA Piper, Trust and Tokeny to offer professional investors the means to participate in the current equity round using both crypto and fiat currency. Deloitte has been selected to provide AML and KYC services. The whitelisting process will begin in October with the round closing in December 2018. The STO is part of Mash’s broader EUR 50 million equity round. Security tokens are not the same as utility tokens, as have been issued in a number of recent initial coin offerings (ICOs). The Mash security tokens are backed by assets and token holders would have voting rights and dividend rights of the comp

Meizu officially launches its Overseas smartphone17.10.2018 15:13Pressemelding

Jakarta, Indonesia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Meizu officially launches its Overseas smartphone, produced in and to be sold in the Indonesian market, the C9, as well as 4 other fantastic products, including the Flagship Meizu 16th, the upgraded M6T, POP true wireless earphones and EP52 Lite. A photo accompanying this announcement is available at https://i.imgur.com/C4LvxTd.png ( Jakarta, Indonesia October 15th, 2018) -- Meizu is releasing 5 exciting products, including 3 smartphone models, its iconic flagship 16th, M6T, C9, POP and EP52 Lite earphones). Meizu’s product launch event is set for the 15th October 2018 at the Pullman hotel in Jakarta Indonesia, with a great line-up of speakers, including Meizu’s Co-Founder and Overseas President Mr Guo, and overseas Head of Marketing and packed with over 150 of Indonesia’s top media, bloggers and fans, it’s set to be a fantastic event all round. Meizu is releasing five great products and introducing 2 years’ warranty on their smartp

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom